Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer

INTRODUCTION: The HOXB13:IL17BR index has been identified to predict clinical outcome in the setting of adjuvant tamoxifen monotherapy of breast cancer. Further studies have shown that HOXB13 in particular can indicate benefit of prolonged tamoxifen treatment. Patients with high-expressing tumors di...

Descripción completa

Detalles Bibliográficos
Autores principales: Jerevall, Piiha-Lotta, Jansson, Agneta, Fornander, Tommy, Skoog, Lambert, Nordenskjöld, Bo, Stål, Olle
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949642/
https://www.ncbi.nlm.nih.gov/pubmed/20649975
http://dx.doi.org/10.1186/bcr2612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949642/
https://www.ncbi.nlm.nih.gov/pubmed/20649975
http://dx.doi.org/10.1186/bcr2612

Ejemplares similares